tirzepatide average weight loss Per Week Tirzepatide causes more weight loss

Untested formulations Semaglutide and tirzepatide are FDA-approved as injectables (an oral tablet version of semaglutide is also approved), but the formulations some drug compounding pharmacies are selling in the form of sublingual drops or dissolving tablets have never been studied in clinical trials

Prog Lipid Res 61:63-72

Queiroz ML, da Rocha MC, Torello CO, et al

The trial was designed to evaluate the effect in this population, over a period of up to five years, of a onceweekly subcutaneously administered dose of 2.4 mg semaglutide (Wegovy) on cardiovascular outcomes compared to placebo

Less sodium than other options